Methyl 2-(3,3-difluoropiperidin-4-yl)acetate hydrochloride, 98%, 10g

2-(3-Bromo-4-(trifluoromethyl)phenyl)acetic acid, 95.0%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)(methyl)amino)hexanoic acid, 98%, 10g

Methyl 2-hydroxy-6-nitrobenzoate, 95.0%, 1g

6-Methylimidazo[1,2-a]pyridine-2-carbaldehyde, 95.0%, 10g

(3aS,7aR)-7a-phenylhexahydro-4H-pyrrolo[3,4-c]pyridine-4,6(5H)-dione, 95%, 50mg

4-[(2-Isopropyl-6-methylphenyl)amino]-4-oxobutanoic acid, 95.0%, 5g

Boc-Guanidine, 95.0%, 10g

1-Oxa-3-azaspiro[4.4]nonan-2-one, 95%, 1g

Methyl 6-fluoropicolinate, 95.0%, 5g

Pipeta microlitro monocanal mLINE® variable, 500 a 5000 µl, 1 unidad

2,2,2-TRIFLUORO-1-(1,2,3,4-TETRAHYDROQUINOLIN-1-YL)ETHAN-1-ONE, 95.0%, 250mg

3-Fluorobenzonitrile, 98.0%, 100g